Renexin CR 200/160mg

DRUG2 trials

Sponsors

SK Chemicals Co., Ltd.

Conditions

Diabetic Peripheral AngiopathyIschemic Stroke

Phase 4

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

CompletedNCT05445895

SK Chemicals Co., Ltd.Ischemic Stroke

Start: 2022-12-16End: 2025-11-07Updated: 2025-11-21

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.

CompletedNCT05906199

SK Chemicals Co., Ltd.Diabetic Peripheral Angiopathy

Start: 2021-07-28End: 2023-12-13Updated: 2025-03-12

Related Papers

Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus.

2025-08-13

Rationale and design of the efficacy and safety of combination of cilostazol and gingko biloba extract EGb 761 in patients with acute non-cardioembolic ischemic stroke (RENEW): A pilot and feasibility randomized controlled trial.

2024-11-10